Answers are grounded in this paper and cite their sources.
This work was to investigate the drug resistance, molecular and virulence characteristics of methicillin-resistant Staphylococcus aureus (MRSA) in burn patients and provide empiric antibiotic therapy for clinical treatment. A total of 365 non duplicate Staphylococcus strains, including 85 MRSA and 280 methicillin-susceptible Staphylococcus aureus (MSSA), were collected from burn patients from 2008 to 2015. The susceptibility tests of antibacterial agents were performed by the Kirby-Bauer disk diffusion method. Polymerase chain reaction (PCR) and gel electrophoresis amplification technology were used to identify the mecA, qacA/B, and virulence genes, such as staphylococcal enterotoxin A (sea), staphylococcal enterotoxin B (seb), panton-valentine leukocidin (PVL), hemolysin A (hla), fibronectin-binding protein A (fnbA) of MRSA. Pulsed field gel electrophoresis (PFGE) was performed to analysis nucleotide homology of MRSA isolates. The resistance rates of MRSA to commonly-used antimicrobial agents were significantly higher than that of MSSA. The PCR assay results showed that all MRSA were mecA-positive and qacA/B-positive strains. The prevalence of virulence gene sea, seb, PVL, hla and fnbA were 70%, 60%, 90%, 85%, 5% in MRSA strains, respectively. Also, the prevalence of virulence genes sea, seb, pvl, hla and fnbA were 40%, 33.3%, 93.3%, 100%, and 20% in MSSA strains, respectively. According to the PFGE analysis, sixteen of MRSA isolates were classified into A, B, and C types and corresponding amounts were 13 (81.25%), 2 (12.5%), and 1 (6.25%), respectively. The burn patients who infected MRSA have a higher drug resistance, and further recognition the molecular characteristics of MRSA is necessary to find better treatment options.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: